Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Scharf

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Infection|March 9, 2026
Antifungal exposure variability in critically ill patients: extending risk-based frameworks in invasive mould infectionsDanilo Hackner, Christina Scharf
Journal of Critical Care|May 27, 2022
Authors response: "Trough concentrations of meropenem and piperacillin during slow extended dialysis in critically ill patients with intermittent and continuous infusion: A prospective observational study"Uwe Liebchen, Christina Scharf
Journal of Critical Care|October 14, 2022
Authors' response: "Serum linezolid concentrations are reduced in critically ill patients with pulmonary infections: A prospective observational study"Michael Zoller, Uwe Liebchen, Christina Scharf
Der Anaesthesist|February 26, 2021
[What is new … in the treatment of invasive mycosis: COVID-19-associated pulmonary aspergillosis]Christina Scharf, Michael Zoller, Uwe Liebchen
Die Anaesthesiologie|February 16, 2023
[What is new … in selective decontamination?]Uwe Liebchen, Josef Briegel, Christina Scharf
Die Anaesthesiologie|August 4, 2022
[Therapeutic drug monitoring and pharmacokinetic models as a strategy for rational antibiotic therapy in intensive care patients]Lea Marie Schatz, Michael Zoller, Christina Scharf, et al.
Intensive Care Medicine|February 10, 2023
The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failureUwe Liebchen, Michael Paal, Caroline Gräfe, et al.
Intensive Care Medicine|September 14, 2021
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb<sup>®</sup> in critically ill patients with sepsis or septic shockUwe Liebchen, Christina Scharf, Michael Zoller, et al.
Die Anaesthesiologie|September 14, 2023
[Hemoperfusion in anesthesia and intensive care medicine: benefits, risks, and evidence for different systems]Caroline Gräfe, Lorenz Weidhase, Uwe Liebchen, et al.
Journal of Medical Case Reports|September 9, 2025
Challenges in the use of the CytoSorb<sup>®</sup> adsorber in an intensive care patient with liver dysfunction of unknown origin: a case reportCaroline Gräfe, Michael Paal, Michael Irlbeck, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Infection|March 9, 2026
Antifungal exposure variability in critically ill patients: extending risk-based frameworks in invasive mould infectionsDanilo Hackner, Christina Scharf
Journal of Critical Care|May 27, 2022
Authors response: "Trough concentrations of meropenem and piperacillin during slow extended dialysis in critically ill patients with intermittent and continuous infusion: A prospective observational study"Uwe Liebchen, Christina Scharf
Journal of Critical Care|October 14, 2022
Authors' response: "Serum linezolid concentrations are reduced in critically ill patients with pulmonary infections: A prospective observational study"Michael Zoller, Uwe Liebchen, Christina Scharf
Der Anaesthesist|February 26, 2021
[What is new … in the treatment of invasive mycosis: COVID-19-associated pulmonary aspergillosis]Christina Scharf, Michael Zoller, Uwe Liebchen
Die Anaesthesiologie|February 16, 2023
[What is new … in selective decontamination?]Uwe Liebchen, Josef Briegel, Christina Scharf
Die Anaesthesiologie|August 4, 2022
[Therapeutic drug monitoring and pharmacokinetic models as a strategy for rational antibiotic therapy in intensive care patients]Lea Marie Schatz, Michael Zoller, Christina Scharf, et al.
Intensive Care Medicine|February 10, 2023
The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failureUwe Liebchen, Michael Paal, Caroline Gräfe, et al.
Intensive Care Medicine|September 14, 2021
No clinically relevant removal of meropenem by cytokine adsorber CytoSorb<sup>®</sup> in critically ill patients with sepsis or septic shockUwe Liebchen, Christina Scharf, Michael Zoller, et al.
Die Anaesthesiologie|September 14, 2023
[Hemoperfusion in anesthesia and intensive care medicine: benefits, risks, and evidence for different systems]Caroline Gräfe, Lorenz Weidhase, Uwe Liebchen, et al.
Journal of Medical Case Reports|September 9, 2025
Challenges in the use of the CytoSorb<sup>®</sup> adsorber in an intensive care patient with liver dysfunction of unknown origin: a case reportCaroline Gräfe, Michael Paal, Michael Irlbeck, et al.
Pageof 8